FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Richard Hollis

Research Profile

Procedures

Chemicals & Drugs

Living Beings

Disorders

Physiology

Activities & Behaviors

Molecular Epidemiology

Co-author Network

Publications

TOP 3
Michael A Pfaller; L B Boyken; Richard J Hollis; J Kroeger; Shawn A Messer; Shailesh Tendolkar; Daniel J Diekema
Validation of 24-hour posaconazole and voriconazole MIC readings versus the CLSI 48-hour broth microdilution reference method: application of epidemiological cutoff values to results from a global Candida antifungal surveillance program.
Michael A Pfaller; Ana Espinel-Ingroff; Linda Boyken; Richard J Hollis; J Kroeger; Shawn A Messer; Shailesh Tendolkar; Daniel J Diekema
Comparison of the broth microdilution (BMD) method of the European Committee on Antimicrobial Susceptibility Testing with the 24-hour CLSI BMD method for testing susceptibility of Candida species to fluconazole, posaconazole, and voriconazole by use of epidemiological cutoff values.
Michael A Pfaller; Linda Boyken; Richard J Hollis; J Kroeger; Shawn Messer; Shailesh Tendolkar; Daniel Diekema
Comparison of the broth microdilution methods of the European Committee on Antimicrobial Susceptibility Testing and the Clinical and Laboratory Standards Institute for testing itraconazole, posaconazole, and voriconazole against Aspergillus isolates.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Richard Hollis (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Michael A Pfaller; L B Boyken; Richard J Hollis; J Kroeger; Shawn A Messer; Shailesh Tendolkar; Daniel J Diekema
Validation of 24-hour posaconazole and voriconazole MIC readings versus the CLSI 48-hour broth microdilution reference method: application of epidemiological cutoff values to results from a global Candida antifungal surveillance program.
Journal of clinical microbiology 2011;49(4):1274-9.
2011: Michael A Pfaller; Ana Espinel-Ingroff; Linda Boyken; Richard J Hollis; J Kroeger; Shawn A Messer; Shailesh Tendolkar; Daniel J Diekema
Comparison of the broth microdilution (BMD) method of the European Committee on Antimicrobial Susceptibility Testing with the 24-hour CLSI BMD method for testing susceptibility of Candida species to fluconazole, posaconazole, and voriconazole by use of epidemiological cutoff values.
Journal of clinical microbiology 2011;49(3):845-50.
2011: Michael A Pfaller; Linda Boyken; Richard J Hollis; J Kroeger; Shawn Messer; Shailesh Tendolkar; Daniel Diekema
Comparison of the broth microdilution methods of the European Committee on Antimicrobial Susceptibility Testing and the Clinical and Laboratory Standards Institute for testing itraconazole, posaconazole, and voriconazole against Aspergillus isolates.
Journal of clinical microbiology 2011;49(3):1110-2.
2011: Michael A Pfaller; Linda Boyken; Richard J Hollis; J Kroeger; Shawn A Messer; Shailesh Tendolkar; Daniel J Diekema
Wild-type MIC distributions and epidemiological cutoff values for posaconazole and voriconazole and Candida spp. as determined by 24-hour CLSI broth microdilution.
Journal of clinical microbiology 2011;49(2):630-7.
2011: Michael A Pfaller; Linda Boyken; Richard J Hollis; J Kroeger; Shawn Messer; Shailesh Tendolkar; Daniel Diekema
Use of epidemiological cutoff values to examine 9-year trends in susceptibility of Candida species to anidulafungin, caspofungin, and micafungin.
Journal of clinical microbiology 2011;49(2):624-9.
2011: Michael A Pfaller; Linda Boyken; Richard J Hollis; J Kroeger; Shawn Messer; Shailesh Tendolkar; Daniel Diekema
Use of epidemiological cutoff values to examine 9-year trends in susceptibility of Aspergillus species to the triazoles.
Journal of clinical microbiology 2011;49(2):586-90.
2010: Michael A Pfaller; Richard J Hollis; B P Goldstein; Shawn Messer; Daniel Diekema; T Henkel
In vitro activity of anidulafungin and other agents against esophageal candidiasis-associated isolates from a phase 3 clinical trial.
Journal of clinical microbiology 2010;48(7):2613-4.
2010: Michael A Pfaller; Linda Boyken; Richard J Hollis; Jennifer Kroeger; Shawn A Messer; Shailesh Tendolkar; Daniel J Diekema
Wild-type minimum effective concentration distributions and epidemiologic cutoff values for caspofungin and Aspergillus spp. as determined by Clinical and Laboratory Standards Institute broth microdilution methods.
Diagnostic microbiology and infectious disease 2010;67(1):56-60.
2010: Michael A Pfaller; Linda Boyken; Richard J Hollis; J Kroeger; Shawn A Messer; Shailesh Tendolkar; Ronald Jones; J Turnidge; Daniel J Diekema
Wild-type MIC distributions and epidemiological cutoff values for the echinocandins and Candida spp.
Journal of clinical microbiology 2010;48(1):52-6.
2009: Daniel J Diekema; Shawn A Messer; L B Boyken; Richard J Hollis; J Kroeger; Shailesh Tendolkar; Michael A Pfaller
In vitro activity of seven systemically active antifungal agents against a large global collection of rare Candida species as determined by CLSI broth microdilution methods.
Journal of clinical microbiology 2009;47(10):3170-7.
2009: Michael A Pfaller; Linda Boyken; Richard J Hollis; J Kroeger; Shawn A Messer; Shailesh Tendolkar; Daniel J Diekema
In vitro susceptibility of clinical isolates of Aspergillus spp. to anidulafungin, caspofungin, and micafungin: a head-to-head comparison using the CLSI M38-A2 broth microdilution method.
Journal of clinical microbiology 2009;47(10):3323-5.
2009: Michael A Pfaller; Shawn A Messer; Richard J Hollis; Linda Boyken; Shailesh Tendolkar; J Kroeger; Daniel J Diekema
Variation in susceptibility of bloodstream isolates of Candida glabrata to fluconazole according to patient age and geographic location in the United States in 2001 to 2007.
Journal of clinical microbiology 2009;47(10):3185-90.
2009: Michael A Pfaller; Linda Boyken; Richard J Hollis; Jennifer Kroeger; Shawn A Messer; Shailesh Tendolkar; Daniel J Diekema
Comparison of results of fluconazole and voriconazole disk diffusion testing for Candida spp. with results from a central reference laboratory in the ARTEMIS DISK Global Antifungal Surveillance Program.
Diagnostic microbiology and infectious disease 2009;65(1):27-34.
2009: Daniel J Diekema; Shawn A Messer; Richard J Hollis; Linda Boyken; Shailesh Tendolkar; Jennifer Kroeger; Ronald N Jones; Michael A Pfaller
A global evaluation of voriconazole activity tested against recent clinical isolates of Candida spp.
Diagnostic microbiology and infectious disease 2009;63(2):233-6.
2008: Michael A Pfaller; L B Boyken; Richard J Hollis; J Kroeger; Shawn A Messer; Shailesh Tendolkar; Daniel J Diekema
Validation of 24-hour fluconazole MIC readings versus the CLSI 48-hour broth microdilution reference method: results from a global Candida antifungal surveillance program.
Journal of clinical microbiology 2008;46(11):3585-90.
2008: Michael A Pfaller; Shawn A Messer; Linda Boyken; Cassie Rice; Shailesh Tendolkar; Richard J Hollis; Daniel J Diekema
In vitro survey of triazole cross-resistance among more than 700 clinical isolates of Aspergillus species.
Journal of clinical microbiology 2008;46(8):2568-72.
2008: Michael A Pfaller; Shawn A Messer; Linda Boyken; Shailesh Tendolkar; Richard J Hollis; Daniel J Diekema
Selection of a surrogate agent (fluconazole or voriconazole) for initial susceptibility testing of posaconazole against Candida spp.: results from a global antifungal surveillance program.
Journal of clinical microbiology 2008;46(2):551-9.
2008: Michael A Pfaller; Linda Boyken; Richard J Hollis; J Kroeger; Shawn A Messer; Shailesh Tendolkar; Daniel J Diekema
In vitro susceptibility of invasive isolates of Candida spp. to anidulafungin, caspofungin, and micafungin: six years of global surveillance.
Journal of clinical microbiology 2008;46(1):150-6.
2007: Daniel J Diekema; Shawn A Messer; Richard J Hollis; Linda B Boyken; Shailesh Tendolkar; Jennifer Kroeger; Michael A Pfaller
Evaluation of Etest and disk diffusion methods compared with broth microdilution antifungal susceptibility testing of clinical isolates of Candida spp. against posaconazole.
Journal of clinical microbiology 2007;45(6):1974-7.
2007: Shawn A Messer; Daniel J Diekema; Richard J Hollis; Linda B Boyken; Shailesh Tendolkar; Jennifer Kroeger; Michael A Pfaller
Evaluation of disk diffusion and Etest compared to broth microdilution for antifungal susceptibility testing of posaconazole against clinical isolates of filamentous fungi.
Journal of clinical microbiology 2007;45(4):1322-4.
2007: Michael A Pfaller; Shawn A Messer; Linda Boyken; Cassie Rice; Shailesh Tendolkar; Richard J Hollis; Daniel J Diekema
Use of fluconazole as a surrogate marker to predict susceptibility and resistance to voriconazole among 13,338 clinical isolates of Candida spp. Tested by clinical and laboratory standards institute-recommended broth microdilution methods.
Journal of clinical microbiology 2007;45(1):70-5.
2006: Michael A Pfaller; Linda Boyken; Richard J Hollis; Shawn A Messer; Shailesh Tendolkar; Daniel J Diekema
Global surveillance of in vitro activity of micafungin against Candida: a comparison with caspofungin by CLSI-recommended methods.
Journal of clinical microbiology 2006;44(10):3533-8.
2006: Michael A Pfaller; Linda Boyken; Richard J Hollis; Shawn A Messer; Shailesh Tendolkar; Daniel J Diekema
In vitro susceptibilities of Candida spp. to caspofungin: four years of global surveillance.
Journal of clinical microbiology 2006;44(3):760-3.
2006: Shawn A Messer; Daniel J Diekema; Linda Boyken; Shailesh Tendolkar; Richard J Hollis; Michael A Pfaller
Activities of micafungin against 315 invasive clinical isolates of fluconazole-resistant Candida spp.
Journal of clinical microbiology 2006;44(2):324-6.
2005: Michael A Pfaller; Linda Boyken; Richard J Hollis; Shawn A Messer; Shailesh Tendolkar; Daniel J Diekema
In vitro activities of anidulafungin against more than 2,500 clinical isolates of Candida spp., including 315 isolates resistant to fluconazole.
Journal of clinical microbiology 2005;43(11):5425-7.
2005: Michael A Pfaller; Daniel J Diekema; Linda Boyken; Shawn A Messer; Shailesh Tendolkar; Richard J Hollis; B P Goldstein
Effectiveness of anidulafungin in eradicating Candida species in invasive candidiasis.
Antimicrobial agents and chemotherapy 2005;49(11):4795-7.
2005: Michael A Pfaller; Linda Boyken; Shawn A Messer; Shailesh Tendolkar; Richard J Hollis; Daniel J Diekema
Comparison of results of voriconazole disk diffusion testing for Candida species with results from a central reference laboratory in the ARTEMIS global antifungal surveillance program.
Journal of clinical microbiology 2005;43(10):5208-13.
2005: Michael A Pfaller; Linda Boyken; Richard J Hollis; Shawn A Messer; Shailesh Tendolkar; Daniel J Diekema
In vitro susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species to itraconazole: global survey of 9,359 isolates tested by clinical and laboratory standards institute broth microdilution methods.
Journal of clinical microbiology 2005;43(8):3807-10.
2005: Michael Klevay; Alex Ebinger; Daniel Diekema; Shawn Messer; Richard J Hollis; Michael A Pfaller
Disk diffusion testing using Candida sp. colonies taken directly from CHROMagar Candida medium may decrease time required to obtain results.
Journal of clinical microbiology 2005;43(7):3497-9.
2005: Michael A Pfaller; Shawn A Messer; Linda Boyken; Cassie Rice; Shailesh Tendolkar; Richard J Hollis; G V Doern; Daniel J Diekema
Global trends in the antifungal susceptibility of Cryptococcus neoformans (1990 to 2004).
Journal of clinical microbiology 2005;43(5):2163-7.
2005: Sandra S Richter; Rudolph P Galask; Shawn A Messer; Richard J Hollis; Daniel J Diekema; Michael A Pfaller
Antifungal susceptibilities of Candida species causing vulvovaginitis and epidemiology of recurrent cases.
Journal of clinical microbiology 2005;43(5):2155-62.
2005: Daniel J Diekema; B Petroelje; Shawn A Messer; Richard J Hollis; Michael A Pfaller
Activities of available and investigational antifungal agents against rhodotorula species.
Journal of clinical microbiology 2005;43(1):476-8.
2004: Michael A Pfaller; Linda Boyken; Shawn A Messer; Shailesh Tendolkar; Richard J Hollis; Daniel J Diekema
Evaluation of the etest method using Mueller-Hinton agar with glucose and methylene blue for determining amphotericin B MICs for 4,936 clinical isolates of Candida species.
Journal of clinical microbiology 2004;42(11):4977-9.
2004: Suzane Silbert; Michael A Pfaller; Richard J Hollis; Afonso L Barth; Helio S Sader
Evaluation of three molecular typing techniques for nonfermentative Gram-negative bacilli.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 2004;25(10):847-51.
2004: Michael A Pfaller; Linda Boyken; Richard J Hollis; Shawn A Messer; Shailesh Tendolkar; Daniel J Diekema
Clinical evaluation of a dried commercially prepared microdilution panel for antifungal susceptibility testing of five antifungal agents against Candida spp. and Cryptococcus neoformans.
Diagnostic microbiology and infectious disease 2004;50(2):113-7.
2004: Michael A Pfaller; K C Hazen; Shawn A Messer; Linda Boyken; Shailesh Tendolkar; Richard J Hollis; Daniel J Diekema
Comparison of results of fluconazole disk diffusion testing for Candida species with results from a central reference laboratory in the ARTEMIS global antifungal surveillance program.
Journal of clinical microbiology 2004;42(8):3607-12.
2004: Michael A Pfaller; Shawn A Messer; Linda Boyken; Shailesh Tendolkar; Richard J Hollis; Daniel J Diekema
Geographic variation in the susceptibilities of invasive isolates of Candida glabrata to seven systemically active antifungal agents: a global assessment from the ARTEMIS Antifungal Surveillance Program conducted in 2001 and 2002.
Journal of clinical microbiology 2004;42(7):3142-6.
2004: Michael A Pfaller; Shawn A Messer; Linda Boyken; Cassie Rice; Shailesh Tendolkar; Richard J Hollis; Daniel J Diekema
Cross-resistance between fluconazole and ravuconazole and the use of fluconazole as a surrogate marker to predict susceptibility and resistance to ravuconazole among 12,796 clinical isolates of Candida spp.
Journal of clinical microbiology 2004;42(7):3137-41.
2004: Michael A Pfaller; Shawn A Messer; Linda Boyken; Cassie Rice; Shailesh Tendolkar; Richard J Hollis; Daniel J Diekema
Further standardization of broth microdilution methodology for in vitro susceptibility testing of caspofungin against Candida species by use of an international collection of more than 3,000 clinical isolates.
Journal of clinical microbiology 2004;42(7):3117-9.
2004: Michael A Pfaller; Shawn A Messer; Linda Boyken; Richard J Hollis; Cassie Rice; Shailesh Tendolkar; Daniel J Diekema
In vitro activities of voriconazole, posaconazole, and fluconazole against 4,169 clinical isolates of Candida spp. and Cryptococcus neoformans collected during 2001 and 2002 in the ARTEMIS global antifungal surveillance program.
Diagnostic microbiology and infectious disease 2004;48(3):201-5.
2004: Michael A Pfaller; Linda Boyken; Shawn A Messer; Richard J Hollis; Daniel J Diekema
Stability of Mueller-Hinton agar supplemented with glucose and methylene blue for disk diffusion testing of fluconazole and voriconazole.
Journal of clinical microbiology 2004;42(3):1288-9.
2004: Michael A Pfaller; Daniel J Diekema; Shawn A Messer; Linda Boyken; Richard J Hollis; Ronald Jones
In vitro susceptibilities of rare Candida bloodstream isolates to ravuconazole and three comparative antifungal agents.
Diagnostic microbiology and infectious disease 2004;48(2):101-5.
2004: Ana Gales; Michael A Pfaller; Helio S Sader; Richard J Hollis; Ronald Jones
Genotypic characterization of carbapenem-nonsusceptible Acinetobacter spp. isolated in Latin America.
Microbial drug resistance (Larchmont, N.Y.) 2004;10(4):286-91.
2004: Michael A Pfaller; Shawn A Messer; Linda Boyken; Cassie Rice; Shailesh Tendolkar; Richard J Hollis; Daniel J Diekema
Evaluation of the NCCLS M44-P disk diffusion method for determining susceptibilities of 276 clinical isolates of Cryptococcus neoformans to fluconazole.
Journal of clinical microbiology 2004;42(1):380-3.
2003: Suzane Silbert; Linda Boyken; Richard J Hollis; Michael A Pfaller
Improving typeability of multiple bacterial species using pulsed-field gel electrophoresis and thiourea.
Diagnostic microbiology and infectious disease 2003;47(4):619-21.
2003: Michael A Pfaller; Shawn A Messer; Linda Boyken; Cassie Rice; Shailesh Tendolkar; Richard J Hollis; Daniel J Diekema
Caspofungin activity against clinical isolates of fluconazole-resistant Candida.
Journal of clinical microbiology 2003;41(12):5729-31.
2003: Arnaldo Lopes Colombo; Analy S Azevedo Melo; Robert F Crespo Rosas; Reinaldo Salomão; Marcelo RS Briones; Richard J Hollis; Shawn A Messer; Michael A Pfaller
Outbreak of Candida rugosa candidemia: an emerging pathogen that may be refractory to amphotericin B therapy.
Diagnostic microbiology and infectious disease 2003;46(4):253-7.
2003: Daniel J Diekema; Shawn A Messer; Richard J Hollis; Ronald Jones; Michael A Pfaller
Activities of caspofungin, itraconazole, posaconazole, ravuconazole, voriconazole, and amphotericin B against 448 recent clinical isolates of filamentous fungi.
Journal of clinical microbiology 2003;41(8):3623-6.
2003: Michael A Pfaller; Shawn A Messer; Linda Boyken; Shailesh Tendolkar; Richard J Hollis; Daniel J Diekema
Variation in susceptibility of bloodstream isolates of Candida glabrata to fluconazole according to patient age and geographic location.
Journal of clinical microbiology 2003;41(5):2176-9.
2003: Michael A Pfaller; Daniel J Diekema; Linda Boyken; Shawn A Messer; Shailesh Tendolkar; Richard J Hollis
Evaluation of the Etest and disk diffusion methods for determining susceptibilities of 235 bloodstream isolates of Candida glabrata to fluconazole and voriconazole.
Journal of clinical microbiology 2003;41(5):1875-80.
2003: Michael A Pfaller; Shawn A Messer; Linda Boyken; Richard J Hollis; Daniel J Diekema
In vitro susceptibility testing of filamentous fungi: comparison of Etest and reference M38-A microdilution methods for determining posaconazole MICs.
Diagnostic microbiology and infectious disease 2003;45(4):241-4.
2003: Michael A Pfaller; Daniel J Diekema; Shawn A Messer; Linda Boyken; Richard J Hollis
Activities of fluconazole and voriconazole against 1,586 recent clinical isolates of Candida species determined by Broth microdilution, disk diffusion, and Etest methods: report from the ARTEMIS Global Antifungal Susceptibility Program, 2001.
Journal of clinical microbiology 2003;41(4):1440-6.
2003: J B Pfaller; Shawn A Messer; Richard J Hollis; Daniel J Diekema; Michael A Pfaller
In vitro susceptibility testing of Aspergillus spp.: comparison of Etest and reference microdilution methods for determining voriconazole and itraconazole MICs.
Journal of clinical microbiology 2003;41(3):1126-9.
2003: M J Maxwell; Shawn A Messer; Richard J Hollis; Linda Boyken; Shailesh Tendolkar; Daniel J Diekema; Michael A Pfaller
Evaluation of Etest method for determining fluconazole and voriconazole MICs for 279 clinical isolates of Candida species infrequently isolated from blood.
Journal of clinical microbiology 2003;41(3):1087-90.
2003: Michael A Pfaller; Daniel J Diekema; Shawn A Messer; Richard J Hollis; Ronald Jones
In vitro activities of caspofungin compared with those of fluconazole and itraconazole against 3,959 clinical isolates of Candida spp., including 157 fluconazole-resistant isolates.
Antimicrobial agents and chemotherapy 2003;47(3):1068-71.
2003: Toshiaki Yamazumi; Michael A Pfaller; Shawn A Messer; AK Houston; Linda Boyken; Richard J Hollis; Itaru Furuta; Ronald Jones
Characterization of heteroresistance to fluconazole among clinical isolates of Cryptococcus neoformans.
Journal of clinical microbiology 2003;41(1):267-72.
2003: M J Maxwell; Shawn A Messer; Richard J Hollis; Daniel J Diekema; Michael A Pfaller
Evaluation of Etest method for determining voriconazole and amphotericin B MICs for 162 clinical isolates of Cryptococcus neoformans.
Journal of clinical microbiology 2003;41(1):97-9.
2003: Michael A Pfaller; Daniel J Diekema; Shawn A Messer; Linda Boyken; Richard J Hollis; Ronald Jones
In vitro activities of voriconazole, posaconazole, and four licensed systemic antifungal agents against Candida species infrequently isolated from blood.
Journal of clinical microbiology 2003;41(1):78-83.
2002: Wen-Liang Yu; Ronald Jones; Richard J Hollis; Shawn A Messer; Douglas J Biedenbach; Lalitagauri M Deshpande; Michael A Pfaller
Molecular epidemiology of extended-spectrum beta-lactamase-producing, fluoroquinolone-resistant isolates of Klebsiella pneumoniae in Taiwan.
Journal of clinical microbiology 2002;40(12):4666-9.
2002: Michael A Pfaller; Shawn A Messer; Linda Boyken; Holly Huynh; Richard J Hollis; Daniel J Diekema
In vitro activities of 5-fluorocytosine against 8,803 clinical isolates of Candida spp.: global assessment of primary resistance using National Committee for Clinical Laboratory Standards susceptibility testing methods.
Antimicrobial agents and chemotherapy 2002;46(11):3518-21.
2002: Elaine Blignaut; Shawn Messer; Richard J Hollis; Michael A Pfaller
Antifungal susceptibility of South African oral yeast isolates from HIV/AIDS patients and healthy individuals.
Diagnostic microbiology and infectious disease 2002;44(2):169-74.
2002: John E Sutphin; Michael A Pfaller; Richard J Hollis; Michael D Wagoner
Donor-to-host transmission of Candida albicans after corneal transplantation.
American journal of ophthalmology 2002;134(1):120-1.
2002: Michael A Pfaller; Shawn A Messer; Richard J Hollis; Ronald Jones; Daniel J Diekema
In vitro activities of ravuconazole and voriconazole compared with those of four approved systemic antifungal agents against 6,970 clinical isolates of Candida spp.
Antimicrobial agents and chemotherapy 2002;46(6):1723-7.
2002: Connie S Price; Holly Huynh; Suzanne Paule; Richard J Hollis; Gary A Noskin; Michael A Pfaller; Lance R Peterson
Comparison of an automated ribotyping system to restriction endonuclease analysis and pulsed-field gel electrophoresis for differentiating vancomycin-resistant Enterococcus faecium isolates.
Journal of clinical microbiology 2002;40(5):1858-61.
2002: Michael A Pfaller; Daniel J Diekema; Shawn A Messer; Linda Boyken; Holly Huynh; Richard J Hollis
Clinical evaluation of a frozen commercially prepared microdilution panel for antifungal susceptibility testing of seven antifungal agents, including the new triazoles posaconazole, ravuconazole, and voriconazole.
Journal of clinical microbiology 2002;40(5):1694-7.
2002: Nancy B McClenny; Haihua Fei; Ellen J Baron; Ana Gales; Allison Houston; Richard J Hollis; Michael A Pfaller
Change in colony morphology of Candida lusitaniae in association with development of amphotericin B resistance.
Antimicrobial agents and chemotherapy 2002;46(5):1325-8.
2002: Michael A Pfaller; Shawn A Messer; Richard J Hollis; Ronald Jones
Antifungal activities of posaconazole, ravuconazole, and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillus spp. and other filamentous fungi: report from SENTRY Antimicrobial Surveillance Program, 2000.
Antimicrobial agents and chemotherapy 2002;46(4):1032-7.
2002: Michael A Pfaller; Daniel J Diekema; Ronald Jones; Shawn A Messer; Richard J Hollis
Trends in antifungal susceptibility of Candida spp. isolated from pediatric and adult patients with bloodstream infections: SENTRY Antimicrobial Surveillance Program, 1997 to 2000.
Journal of clinical microbiology 2002;40(3):852-6.
2001: Michael A Pfaller; Shawn A Messer; Richard J Hollis; Ronald Jones
In vitro activities of posaconazole (Sch 56592) compared with those of itraconazole and fluconazole against 3,685 clinical isolates of Candida spp. and Cryptococcus neoformans.
Antimicrobial agents and chemotherapy 2001;45(10):2862-4.
2001: Michael A Pfaller; D J Diekema; Ronald Jones; Helio S Sader; A C Fluit; Richard J Hollis; S A Messer
International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobial surveillance program.
Journal of clinical microbiology 2001;39(9):3254-9.
2000: Y F Berrouane; louise-anne mcnutt; BJ Buschelman; Paul R Rhomberg; M D Sanford; Richard J Hollis; Michael A Pfaller; Loreen A Herwaldt
Outbreak of severe Pseudomonas aeruginosa infections caused by a contaminated drain in a whirlpool bathtub.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2000;31(6):1331-7.
2000: Toshiaki Yamazumi; Michael A Pfaller; Shawn A Messer; AK Houston; Richard J Hollis; Ronald Jones
In vitro activities of ravuconazole (BMS-207147) against 541 clinical isolates of Cryptococcus neoformans.
Antimicrobial agents and chemotherapy 2000;44(10):2883-6.
2000: Michael A Pfaller; I Mujeeb; Richard J Hollis; Ronald Jones; G V Doern
Evaluation of the discriminatory powers of the Dienes test and ribotyping as typing methods for Proteus mirabilis.
Journal of clinical microbiology 2000;38(3):1077-80.
2000: Michael A Pfaller; Ronald Jones; G V Doern; Helio S Sader; Shawn A Messer; AK Houston; Stacy Coffman; Richard J Hollis
Bloodstream infections due to Candida species: SENTRY antimicrobial surveillance program in North America and Latin America, 1997-1998.
Antimicrobial agents and chemotherapy 2000;44(3):747-51.
2000: Patricia L Winokur; M V Eidelstain; OU Stetsiouk; Leonid S Stratchounski; J Blahova; G K Reshedko; MA Croco; Richard J Hollis; Michael A Pfaller; Ronald Jones
Russian Klebsiella pneumoniae isolates that express extended-spectrum beta-lactamases.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2000;6(2):103-8.
1999: MS Rangel-Frausto; Paul R Rhomberg; Richard J Hollis; Michael A Pfaller; Richard P Wenzel; C M Helms; Loreen A Herwaldt
Persistence of Legionella pneumophila in a hospital's water system: a 13-year survey.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 1999;20(12):793-7.
1999: Michael A Pfaller; Ronald Jones; G V Doern; A C Fluit; Jan Verhoef; Helio S Sader; Shawn A Messer; AK Houston; Stacy Coffman; Richard J Hollis
International surveillance of blood stream infections due to Candida species in the European SENTRY Program: species distribution and antifungal susceptibility including the investigational triazole and echinocandin agents. SENTRY Participant Group (Europe).
Diagnostic microbiology and infectious disease 1999;35(1):19-25.
1999: Daniel J Diekema; Michael A Pfaller; Shawn A Messer; AK Houston; Richard J Hollis; G V Doern; Ronald Jones
In vitro activities of BMS-207147 against over 600 contemporary clinical bloodstream isolates of Candida species from the SENTRY Antimicrobial Surveillance Program in North America and Latin America.
Antimicrobial agents and chemotherapy 1999;43(9):2236-9.
1999: Richard J Hollis; J L Bruce; S J Fritschel; Michael A Pfaller
Comparative evaluation of an automated ribotyping instrument versus pulsed-field gel electrophoresis for epidemiological investigation of clinical isolates of bacteria.
Diagnostic microbiology and infectious disease 1999;34(4):263-8.
1999: J C Seguin; Robert D Walker; John P Caron; Wesley E Kloos; Carol G George; Richard J Hollis; Ronald Jones; Michael A Pfaller
Methicillin-resistant Staphylococcus aureus outbreak in a veterinary teaching hospital: potential human-to-animal transmission.
Journal of clinical microbiology 1999;37(5):1459-63.
1999: Michael A Pfaller; Shawn A Messer; Richard J Hollis; Ronald Jones; G V Doern; Mary E Brandt; RA Hajjeh
Trends in species distribution and susceptibility to fluconazole among blood stream isolates of Candida species in the United States.
Diagnostic microbiology and infectious disease 1999;33(4):217-22.
1999: C Wendt; Shawn A Messer; Richard J Hollis; Michael A Pfaller; Richard P Wenzel; Loreen A Herwaldt
Recurrent gram-negative bacteremia: incidence and clinical patterns.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1999;28(3):611-7.
1999: C Wendt; Shawn A Messer; Richard J Hollis; Michael A Pfaller; Richard P Wenzel; Loreen A Herwaldt
Molecular epidemiology of gram-negative bacteremia.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1999;28(3):605-10.
1998: Michael A Pfaller; Shawn A Messer; Richard J Hollis; Ronald Jones; G V Doern; Mary E Brandt; RA Hajjeh
In vitro susceptibilities of Candida bloodstream isolates to the new triazole antifungal agents BMS-207147, Sch 56592, and voriconazole.
Antimicrobial agents and chemotherapy 1998;42(12):3242-4.
1998: C Savor; Michael A Pfaller; JA Kruszynski; Richard J Hollis; Gary A Noskin; Lance R Peterson
Comparison of genomic methods for differentiating strains of Enterococcus faecium: assessment using clinical epidemiologic data.
Journal of clinical microbiology 1998;36(11):3327-31.
1998: C Wendt; Shawn A Messer; Richard J Hollis; Michael A Pfaller; Loreen A Herwaldt
Epidemiology of polyclonal gram-negative bacteremia.
Diagnostic microbiology and infectious disease 1998;32(1):9-13.
1998: Michael A Pfaller; Shawn A Messer; Richard J Hollis; Ana Espinel-Ingroff; Mahmoud A Ghannoum; H Plavan; Scott B Killian; C C Knapp
Multisite reproducibility of MIC results by the Sensititre YeastOne colorimetric antifungal susceptibility panel.
Diagnostic microbiology and infectious disease 1998;31(4):543-7.
1998: Michael A Pfaller; Ronald Jones; G V Doern; Helio S Sader; Richard J Hollis; Shawn A Messer
International surveillance of bloodstream infections due to Candida species: frequency of occurrence and antifungal susceptibilities of isolates collected in 1997 in the United States, Canada, and South America for the SENTRY Program. The SENTRY Participant Group.
Journal of clinical microbiology 1998;36(7):1886-9.
1998: Sandra L Fowler; B Rhoton; S C Springer; S A Messer; Richard J Hollis; Michael A Pfaller
Evidence for person-to-person transmission of Candida lusitaniae in a neonatal intensive-care unit.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 1998;19(5):343-5.
1998: Ronald Jones; Michael A Pfaller; G V Doern; ME Erwin; Richard J Hollis
Antimicrobial activity and spectrum investigation of eight broad-spectrum beta-lactam drugs: a 1997 surveillance trial in 102 medical centers in the United States. Cefepime Study Group.
Diagnostic microbiology and infectious disease 1998;30(3):215-28.
1997: Ronald Jones; Michael A Pfaller; SA Marshall; Richard J Hollis; Werner W Wilke
Antimicrobial activity of 12 broad-spectrum agents tested against 270 nosocomial blood stream infection isolates caused by non-enteric gram-negative bacilli: occurrence of resistance, molecular epidemiology, and screening for metallo-enzymes.
Diagnostic microbiology and infectious disease 1997;29(3):187-92.
1997: Daniel J Diekema; Shawn A Messer; Richard J Hollis; Richard P Wenzel; Michael A Pfaller
An outbreak of Candida parapsilosis prosthetic valve endocarditis.
Diagnostic microbiology and infectious disease 1997;29(3):147-53.
1997: Ronald Jones; SA Marshall; Michael A Pfaller; Werner W Wilke; Richard J Hollis; ME Erwin; Michael B Edmond; Richard P Wenzel
Nosocomial enterococcal blood stream infections in the SCOPE Program: antimicrobial resistance, species occurrence, molecular testing results, and laboratory testing accuracy. SCOPE Hospital Study Group.
Diagnostic microbiology and infectious disease 1997;29(2):95-102.
1997: Michael A Pfaller; Ronald Jones; SA Marshall; Stacy Coffman; Richard J Hollis; Michael B Edmond; Richard P Wenzel
Inducible amp C beta-lactamase producing gram-negative bacilli from blood stream infections: frequency, antimicrobial susceptibility, and molecular epidemiology in a national surveillance program (SCOPE).
Diagnostic microbiology and infectious disease 1997;28(4):211-9.
1997: J Zhang; Richard J Hollis; Michael A Pfaller
Variations in DNA subtype and antifungal susceptibility among clinical isolates of Candida tropicalis.
Diagnostic microbiology and infectious disease 1997;27(3):63-7.
1996: Mark W Garrison; D E Anderson; D M Campbell; Karen C Carroll; C L Malone; J D Anderson; Richard J Hollis; Michael A Pfaller
Stenotrophomonas maltophilia: emergence of multidrug-resistant strains during therapy and in an in vitro pharmacodynamic chamber model.
Antimicrobial agents and chemotherapy 1996;40(12):2859-64.
1996: P A Meier; C D Carter; S E Wallace; Richard J Hollis; Michael A Pfaller; Loreen A Herwaldt
A prolonged outbreak of methicillin-resistant Staphylococcus aureus in the burn unit of a tertiary medical center.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 1996;17(12):798-802.
1996: L Zerva; Richard J Hollis; Michael A Pfaller
In vitro susceptibility testing and DNA typing of Saccharomyces cerevisiae clinical isolates.
Journal of clinical microbiology 1996;34(12):3031-4.
1996: Christopher J Papasian; J Kinney; Stacy Coffman; Richard J Hollis; Michael A Pfaller
Transmission of Citrobacter koseri from mother to infant documented by ribotyping and pulsed-field gel electrophoresis.
Diagnostic microbiology and infectious disease 1996;26(2):63-7.
1996: Y F Berrouane; Richard J Hollis; Michael A Pfaller
Strain variation among and antifungal susceptibilities of isolates of Candida krusei.
Journal of clinical microbiology 1996;34(7):1856-8.
1996: M G Cormican; Richard J Hollis; Michael A Pfaller
DNA macrorestriction profiles and antifungal susceptibility of Candida (Torulopsis) glabrata.
Diagnostic microbiology and infectious disease 1996;25(2):83-7.
1996: Michael A Pfaller; Christine H Wendt; Richard J Hollis; Richard P Wenzel; S J Fritschel; J J Neubauer; Loreen A Herwaldt
Comparative evaluation of an automated ribotyping system versus pulsed-field gel electrophoresis for epidemiological typing of clinical isolates of Escherichia coli and Pseudomonas aeruginosa from patients with recurrent gram-negative bacteremia.
Diagnostic microbiology and infectious disease 1996;25(1):1-8.
1996: L A Waggoner-Fountain; M W Walker; Richard J Hollis; Michael A Pfaller; J E Ferguson; Richard P Wenzel; Leigh Grossman Donowitz
Vertical and horizontal transmission of unique Candida species to premature newborns.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1996;22(5):803-8.
1995: Francesco Barchiesi; Richard J Hollis; S A Messer; G Scalise; Michael G Rinaldi; Michael A Pfaller
Electrophoretic karyotype and in vitro antifungal susceptibility of Cryptococcus neoformans isolates from AIDS patients.
Diagnostic microbiology and infectious disease 1995;23(3):99-103.
1995: Francesco Barchiesi; Richard J Hollis; Maurizio Del Poeta; D A McGough; Giorgio Scalise; Michael G Rinaldi; Michael A Pfaller
Transmission of fluconazole-resistant Candida albicans between patients with AIDS and oropharyngeal candidiasis documented by pulsed-field gel electrophoresis.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1995;21(3):561-4.
1995: Theresa A Schlager; T S Whittam; J Owen Hendley; Richard J Hollis; Michael A Pfaller; R A Wilson; A Stapleton
Comparison of expression of virulence factors by Escherichia coli causing cystitis and E. coli colonizing the periurethra of healthy girls.
The Journal of infectious diseases 1995;172(3):772-7.
1995: Richard J Hollis; J L Barr; Bradley Doebbeling; Michael A Pfaller; Richard P Wenzel
Familial carriage of methicillin-resistant Staphylococcus aureus and subsequent infection in a premature neonate.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1995;21(2):328-32.
1995: Michael B Edmond; Richard J Hollis; A K Houston; Richard P Wenzel
Molecular epidemiology of an outbreak of meningococcal disease in a university community.
Journal of clinical microbiology 1995;33(8):2209-11.
1995: Helio S Sader; Richard J Hollis; Michael A Pfaller
The use of molecular techniques in the epidemiology and control of infectious diseases.
Clinics in laboratory medicine 1995;15(2):407-31.
1995: Jan A J W Kluytmans; Willem B van Leeuwen; W H F Goessens; Richard J Hollis; S Messer; Loreen A Herwaldt; H Bruining; M Heck; J Rost; N van Leeuwen
Food-initiated outbreak of methicillin-resistant Staphylococcus aureus analyzed by pheno- and genotyping.
Journal of clinical microbiology 1995;33(5):1121-8.
1995: D R Reagan; Michael A Pfaller; Richard J Hollis; Richard P Wenzel
Evidence of nosocomial spread of Candida albicans causing bloodstream infection in a neonatal intensive care unit.
Diagnostic microbiology and infectious disease 1995;21(4):191-4.
1995: Francesco Barchiesi; Richard J Hollis; D A McGough; Giorgio Scalise; Michael G Rinaldi; Michael A Pfaller
DNA subtypes and fluconazole susceptibilities of Candida albicans isolates from the oral cavities of patients with AIDS.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1995;20(3):634-40.
1995: Andreas Voss; Michael A Pfaller; Richard J Hollis; J Rhine-Chalberg; Bradley Doebbeling
Investigation of Candida albicans transmission in a surgical intensive care unit cluster by using genomic DNA typing methods.
Journal of clinical microbiology 1995;33(3):576-80.
1995: Michael A Pfaller; S A Messer; Richard J Hollis
Variations in DNA subtype, antifungal susceptibility, and slime production among clinical isolates of Candida parapsilosis.
Diagnostic microbiology and infectious disease 1995;21(1):9-14.
1994: Michael A Pfaller; S A Messer; Richard J Hollis
Strain delineation and antifungal susceptibilities of epidemiologically related and unrelated isolates of Candida lusitaniae.
Diagnostic microbiology and infectious disease 1994;20(3):127-33.
1994: Helio S Sader; Michael A Pfaller; Fred C Tenover; Richard J Hollis; Ronald Jones
Evaluation and characterization of multiresistant Enterococcus faecium from 12 U.S. medical centers.
Journal of clinical microbiology 1994;32(11):2840-2.
1994: C Ferra; Bradley Doebbeling; Richard J Hollis; Michael A Pfaller; C K Lee; R D Gingrich
Candida tropicalis vertebral osteomyelitis: a late sequela of fungemia.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1994;19(4):697-703.
1994: M Sabria-Leal; Michael A Pfaller; V H Morthland; S A Young; Richard J Hollis; L Werkmeister; R L Kleiman-Wexler; Kimberly Ephgrave
Molecular epidemiology of gastric colonization by Enterococcus faecalis in a surgical intensive care unit.
Diagnostic microbiology and infectious disease 1994;19(4):197-202.
1994: Bradley Doebbeling; D R Reagan; Michael A Pfaller; A K Houston; Richard J Hollis; Richard P Wenzel
Long-term efficacy of intranasal mupirocin ointment. A prospective cohort study of Staphylococcus aureus carriage.
Archives of internal medicine 1994;154(13):1505-8.
1994: Helio S Sader; Trish M Perl; Richard J Hollis; D Divishek; Loreen A Herwaldt; Ronald Jones
Nosocomial transmission of Serratia odorifera biogroup. 2: Case report demonstration by macrorestriction analysis of chromosomal DNA using pulsed-field gel electrophoresis.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 1994;15(6):390-3.
1994: Helio S Sader; A C C Pignatari; Richard J Hollis; Ronald Jones
Evaluation of interhospital spread of methicillin-resistant Staphylococcus aureus in Sao Paulo, Brazil, using pulsed-field gel electrophoresis of chromosomal DNA.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 1994;15(5):320-3.
1994: Andreas Voss; Richard J Hollis; Michael A Pfaller; Richard P Wenzel; Bradley Doebbeling
Investigation of the sequence of colonization and candidemia in nonneutropenic patients.
Journal of clinical microbiology 1994;32(4):975-80.
1994: Helio S Sader; A C C Pignatari; R Frei; Richard J Hollis; Ronald Jones
Pulsed-field gel electrophoresis of restriction-digested genomic DNA and antimicrobial susceptibility of Xanthomonas maltophilia strains from Brazil, Switzerland and the USA.
The Journal of antimicrobial chemotherapy 1994;33(3):615-8.
1994: Fred C Tenover; R Arbeit; G Archer; James W Biddle; S Byrne; R Goering; G Hancock; G A Hébert; B Hill; Richard J Hollis
Comparison of traditional and molecular methods of typing isolates of Staphylococcus aureus.
Journal of clinical microbiology 1994;32(2):407-15.
1993: Helio S Sader; A C C Pignatari; I L Leme; M N Burattini; R Tancresi; Richard J Hollis; Ronald Jones
Epidemiologic typing of multiply drug-resistant Pseudomonas aeruginosa isolated from an outbreak in an intensive care unit.
Diagnostic microbiology and infectious disease 1993;17(1):13-8.
1993: Helio S Sader; A C C Pignatari; Richard J Hollis; I Leme; Ronald Jones
Oxacillin- and quinolone-resistant Staphylococcus aureus in Sao Paulo, Brazil: a multicenter molecular epidemiology study.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 1993;14(5):260-4.
1993: Bradley Doebbeling; Paul F Lehmann; Richard J Hollis; L C Wu; A F Widmer; Andreas Voss; Michael A Pfaller
Comparison of pulsed-field gel electrophoresis with isoenzyme profiles as a typing system for Candida tropicalis.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1993;16(3):377-83.
1993: Antoni Trilla; Mary D Nettleman; Richard J Hollis; M Fredrickson; Richard P Wenzel; Michael A Pfaller
Restriction endonuclease analysis of plasmid DNA from methicillin-resistant Staphylococcus aureus: clinical application over a three-year period.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 1993;14(1):29-35.
1993: J N Rodrigues; J L Amaral; I L Leme; A C C Pignatari; S Wey; Richard J Hollis; Michael A Pfaller; Ronald Jones
Molecular epidemiology and antimicrobial susceptibility testing. Testing of quinolone-resistant Staphylococcus aureus strains isolated in Brazil.
Diagnostic microbiology and infectious disease 1993;16(1):9-16.
1993: M Bale; M Sanford; Richard J Hollis; Michael A Pfaller
Application of a biotyping system and DNA restriction fragment analysis to the study of Serratia marcescens from hospitalized patients.
Diagnostic microbiology and infectious disease 1993;16(1):1-7.
1992: Trish M Perl; T H Haugen; Michael A Pfaller; Richard J Hollis; A D Lakeman; R J Whitley; D Nicholson; G A Hunter; Richard P Wenzel
Transmission of herpes simplex virus type 1 infection in an intensive care unit.
Annals of internal medicine 1992;117(7):584-6.
1992: A C C Pignatari; Linda Boyken; Loreen A Herwaldt; Richard J Hollis; I Leme; Ricardo Sesso; Michael A Pfaller
Application of restriction endonuclease analysis of chromosomal DNA in the study of Staphylococcus aureus colonization in continuous ambulatory peritoneal dialysis patients.
Diagnostic microbiology and infectious disease 1992;15(3):195-9.
1992: Loreen A Herwaldt; Richard J Hollis; Linda Boyken; Michael A Pfaller
Molecular epidemiology of coagulase-negative staphylococci isolated from immunocompromised patients.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 1992;13(2):86-92.
1992: Bradley Doebbeling; Michael A Pfaller; Richard J Hollis; Linda Boyken; A C C Pignatari; Loreen A Herwaldt; Richard P Wenzel
Restriction endonuclease analysis of Staphylococcus aureus plasmid DNA from three continents.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1992;11(1):4-8.
1991: D Levenson; Michael A Pfaller; Miriam Smith; Richard J Hollis; T Gerarden; C B Tucci; H D Isenberg
Candida zeylanoides: another opportunistic yeast.
Journal of clinical microbiology 1991;29(8):1689-92.
1991: Bradley Doebbeling; Richard J Hollis; H D Isenberg; Richard P Wenzel; Michael A Pfaller
Restriction fragment analysis of a Candida tropicalis outbreak of sternal wound infections.
Journal of clinical microbiology 1991;29(6):1268-70.
1991: Michael A Pfaller; Douglas S Wakefield; Richard J Hollis; M Fredrickson; E Evans; Robert Michael Massanari
The clinical microbiology laboratory as an aid in infection control. The application of molecular techniques in epidemiologic studies of methicillin-resistant Staphylococcus aureus.
Diagnostic microbiology and infectious disease 1991;14(3):209-17.
1991: D R Reagan; Bradley Doebbeling; Michael A Pfaller; C T Sheetz; A K Houston; Richard J Hollis; Richard P Wenzel
Elimination of coincident Staphylococcus aureus nasal and hand carriage with intranasal application of mupirocin calcium ointment.
Annals of internal medicine 1991;114(2):101-6.
1990: D R Reagan; Michael A Pfaller; Richard J Hollis; Richard P Wenzel
Characterization of the sequence of colonization and nosocomial candidemia using DNA fingerprinting and a DNA probe.
Journal of clinical microbiology 1990;28(12):2733-8.
1990: Michael A Pfaller; I Cabezudo; Richard J Hollis; B Huston; Richard P Wenzel
The use of biotyping and DNA fingerprinting in typing Candida albicans from hospitalized patients.
Diagnostic microbiology and infectious disease 1990;13(6):481-9.
1990: A C C Pignatari; Michael A Pfaller; Richard J Hollis; Ricardo Sesso; I Leme; Loreen A Herwaldt
Staphylococcus aureus colonization and infection in patients on continuous ambulatory peritoneal dialysis.
Journal of clinical microbiology 1990;28(9):1898-902.
1989: Michael A Pfaller; Richard J Hollis; W Johnson; Robert Michael Massanari; C Helms; Richard P Wenzel; N Hall; N Moyer; J Joly
The application of molecular and immunologic techniques to study the epidemiology of Legionella pneumophila serogroup 1.
Diagnostic microbiology and infectious disease 1989;12(4):295-302.
1989: M D Wolf; Michael A Pfaller; Richard J Hollis; T A Weingeist
Staphylococcus aureus conjunctivitis and sepsis in a neutropenic patient.
American journal of ophthalmology 1989;107(1):87-8.
1987: Richard J Hollis; A A Kennaugh; S V Butterworth; A Malcolm R Taylor
Growth of large chromosomally abnormal T cell clones in ataxia telangiectasia patients is associated with translocation at 14q11. A model for other T cell neoplasia.
Human genetics 1987;76(4):389-95.
1980: J H Kaplan; Richard J Hollis
External Na dependence of ouabain-sensitive ATP:ADP exchange initiated by photolysis of intracellular caged-ATP in human red cell ghosts.
Nature 1980;288(5791):587-9.